✦ LIBER ✦

Non-cytotoxic CD4 tumourinfiltrating lymphocytes induce responses in patients with metastatic renal cell carcinoma previously treated with interleukin-2

✍ Scribed by C. Mathiot; N. Thiounn; E. Tartour; T. Flam; C. Peyret; I. Joyeux; M. Zerbib; M. Brandely; B. Debré; W.H. Fridman

Book ID: 116166374
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 277 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00235-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of talactoferrin in previo

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma

✍ Eric Jonasch; Walter M. Stadler; Ronald M. Bukowski; Teresa G. Hayes; Atul Varad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract ## BACKGROUND. Talactoferrin (TLF), a recombinant form of human lactoferrin (hLF), is an immunomodulatory iron‐binding glycoprotein first identified in breast milk. Its immunomodulatory functions include activation of natural killer (NK) and lymphokine‐activated killer cells and enhanc

Prognostic markers for survival in patie

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

✍ Rutger L. van Bezooijen; H. Goey; Gerrit Stoter; J. Hermans; G. J. Fleuren 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 473 KB

Immunotherapy with interleukin-2 (IL2) a

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

✍ Escudier, B; Farace, F; Angevin, E; Charpentier, F; Nitenberg, G; Triebel, F; He 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Interleukin-2 dose, blood monocyte and C

Interleukin-2 dose, blood monocyte and CD25+lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Variable expression of the interleukin-2

Variable expression of the interleukin-2 receptor alpha chain and MYC genes in lymphocytes from renal cell carcinoma patients treated with interleukin-2

✍ Hayat, K.; Finnegan, M.; Lee, K.A.; Rees, R.C.; Hancock, B.W.; Goyns, M.H. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 642 KB

C-REACTIVE PROTEIN: A BIOMARKER OF SURVI

C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

✍ CASAMASSIMA, ADDOLORATA; PICCIARIELLO, MARGHERITA; QUARANTA, MICHELE; BERARDINO, 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 75 KB